Inhibiting multi-functional aldoa for cancer therapy

Ended Project Grant Awarded Last action

Award ID
R01CA216424
Recipient
Awarding agency
Obligated
$4,192,845

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Funding
  • $3,688,257.69 Federal
  • $504,587.00 Non-federal
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$217,408 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $498,144 $0
Amendment $498,144 $0
Amendment $282,172 $0
Amendment -$282,172 $0
Amendment -$282,172 $0
Amendment $282,172 $0
Amendment -$282,172 $0
Amendment $282,172 $0
Amendment $282,172 $0
Amendment -$282,172 $0
Amendment $0 $0
Amendment $504,587 $0
Amendment $0 $0
Amendment Inhibiting multi-functional ALDOA for cancer therapy - fructose-bisphosphate aldolase a (ALDOA) is an ancient, highly expressed gene that has acquired three… $504,587 $504,587
Amendment $63,181 $0
Amendment $568,622 $0
Amendment $612,848 $0
Original award $655,553 $0
Show all 26

Quick answers

Who received award R01CA216424?

R01CA216424 was awarded to Phusis Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on January 12, 2018.

How much is award R01CA216424 worth?

$4,192,845 has been obligated on R01CA216424: $3,688,258 in federal funding and $504,587 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award